Photoacoustic Imaging Market growing at a CAGR of 19.4% from 2025 to 2030
The global photoacoustic imaging market size was estimated at USD 117.5 million in 2024 and is projected to reach USD 339.0 million by 2030, growing at a CAGR of 19.4% from 2025 to 2030. The growth of the market is driven by the increasing incidence of cancer, primarily breast cancer, and rising research studies in non-ionizing radiation for imaging.
Key Market Trends & Insights
- North America photoacoustic imaging market dominated the global market with the largest revenue share of 35.7% in 2024.
- The photoacoustic imaging market in the U.S. led North America and held the largest revenue share in 2024.
- By imaging type, the pre-clinical segment led the global photoacoustic imaging industry and held the largest revenue share of 78.2% in 2024.
- By application, the oncology segment held the dominant position in the market, with the highest revenue share of 39.3% in 2024.
Market Size & Forecast
- 2024 Market Size: USD 117.5 Million
- 2030 Projected Market Size: USD 339.0 Million
- CAGR (2025-2030): 19.4%
- North America: Largest market in 2024
Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/photoacoustic-imaging-market-report/request/rs1
In addition, the growing scope of applications is equally contributing to the market expansion. Furthermore, photoacoustic imaging (PAI) is superior to other diagnostic imaging systems as it uses non-ionizing radiation to examine tissues in real-time with high resolution and contrast at long penetration depths, allowing morphological, functional, and molecular imaging of living subjects. Photoacoustic imaging (PAI) represents a sophisticated technique in biomedical imaging that operates without invasive procedures. This method generates ultrasonic waves when pulsed laser light is directed at the tissue, allowing for the reconstruction of images based on how light energy is absorbed within the tissue.
The market for photoacoustic imaging is currently experiencing substantial growth, largely due to the rising incidence of chronic illnesses, including cancer, cardiovascular diseases, and neurological disorders. For example, projections from the American Cancer Society indicate that breast cancer will remain a critical health issue in the U.S., with an estimated 310,720 new cases of invasive breast cancer and 56,500 cases of ductal carcinoma in situ (DCIS) anticipated in 2024. This alarming statistic highlights the need for precise and timely diagnostic methods to enhance patient outcomes. Photoacoustic imaging stands out by delivering high-resolution, real-time images that merge the advantages of optical imaging with ultrasound’s depth penetration capabilities.
Technological innovations such as research and development in photoacoustic imaging systems aim to enhance their resolution, sensitivity, and clinical utility, which are anticipated to boost product demand over the forecast period. Optical and ultrasonic imaging advantages are combined in near-infrared photoacoustic imaging (NIR-PAI), which delivers high-resolution anatomical and functional information about tissues. PAI offers a unique combination of structural and functional information, making it valuable for early disease detection and monitoring.
Furthermore, the growth of the photoacoustic imaging market is also fueled by increasing investments in healthcare infrastructure. Both government and private sectors are channeling significant resources into improving healthcare facilities, especially in emerging markets. These investments cover many healthcare needs, from building new medical facilities to acquiring cutting-edge diagnostic technologies such as photoacoustic imaging systems. In many developing regions, there is a concentrated effort to enhance medical infrastructure to meet the rising demand for superior healthcare services and advanced diagnostic capabilities.
Photoacoustic Imaging Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 140.0 million |
|
Revenue forecast in 2030 |
USD 339.0 million |
|
Growth rate |
CAGR of 19.4% from 2025 to 2030 |
|
Base year for estimation |
2024 |
|
Historical data |
2018 – 2023 |
|
Forecast period |
2025 – 2030 |
|
Quantitative units |
Revenue in USD million/billion, and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
|
Segments covered |
Product, imaging type, application, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
Advantest Corp.; TomoWave; Kibero GmbH; FUJIFILM VisualSonics Inc.; Seno Medical Instruments; iThera Medical GmbH; Aspectus GmbH; Vibronix Inc. |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |